Please login to the form below

Not currently logged in
Email:
Password:

Fresenius

This page shows the latest Fresenius news and features for those working in and with pharma, biotech and healthcare.

ChemoCentryx surges on phase 3 vasculitis study

ChemoCentryx surges on phase 3 vasculitis study

The positive results set up regulatory filings in both the US and Europe next year, according to  ChemoCentryx, which has licensed ex-US rights to Switzerland’s Vifor Fresenius Medical Care ... Renal Pharma (VFMCRP), a joint venture between Vifor

Latest news

More from news
Approximately 7 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    business. The ancestors of these business model genera could already be seen in, for example, Roche, Mylan and Fresenius but in each case we have seen increasing specialisation and, consequently, differentiation.

  • Case study: What we're made of Case study: What we're made of

    Client:Fresenius Kabi. Agency:Page &Page. Campaign:What we're made of. Timescale:N/A. Malnutrition and dehydration cost the NHS over £19.6 billion annually. ... This empathetic approach has provided a halo effect for Fresenius Kabi’s reputation, as

  • KAM 2.0 KAM 2.0

    The Fresenius Helios hospital group, based in Germany, recently acquired the Spanish hospital group Grupo Hospitalario Quirónsalud to become the largest hospital group in Europe.

  • Pharma deals continue to slide Pharma deals continue to slide

    For example, Fresenius’s acquisition of NxStage Medical (US), a home dialysis competitor, for $2bn is being financed with cash and debt. ... Even so the Fresenius shareholders do not seem worried as the share price remained much the same after the

  • Deal Watch - May 2017 Deal Watch - May 2017

    following an announcement as seen with BD and Cardinal Health.  It is encouraging, therefore, to see Fresenius’s share price increase by 2% following the announcement that its subsidiary Fresenius Kabi ... 6, 100. Akorn (US). Fresenius (DE). Company

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Hikma appoints group scientific officer and global head of R&D Hikma appoints group scientific officer and global head of R&D

    He joins the pharma group from Fresenius Kabi, where he most recently led its US innovation and development centre. ... Prior to this, he served as chief scientific officer for Sabur Pharma, an oncology company that was acquired by Fresenius in 2008.

  • Galenica Group strengthens management team Galenica Group strengthens management team

    Currently chief executive of Vifor Fresenius Medical Care Renal Pharma (VFMCRP), Schulze (pictured right) will take up his new roles in May 2017 reporting to Etienne Jornod, executive chairman of the ... development at Fresenius Medical Care for North

  • Zytoprotec expands supervisory board Zytoprotec expands supervisory board

    He served as vice president of biosciences at Fresenius Medical Care, a medical devices and services firm, as well as its global scientific ambassador between 1996 and 2013.

  • Bartenbach adds to healthcare management team Bartenbach adds to healthcare management team

    Anja Treiber has worked with CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma. ... In the last two years, Treiber has focused on international pharma clients including CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma.

  • Par hires Antonio Pera as commercial head Par hires Antonio Pera as commercial head

    His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories.

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....